Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PMCF Study to Provide Safety, Performance, and Clinical Benefits Data of the Longevity IT Oblique and Offset Liners in Primary and Revision Total Hip Arthroplasty - A Retrospective Enrollment/Prospective Follow-up Consecutive Series Study

NCT05980234 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT05980234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05980234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PMCF Study to Provide Safety, Performance, and Clinical Benefits Data of the Longevity IT Oblique and Offset Liners in Primary and Revision Total Hip Arthroplasty - A Retrospective Enrollment/Prospective Follow-up Consecutive Series Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Terminated
Start date
August 30, 2023
Completion date
November 7, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, diastrophic variant, fracture of the pelvis, fused hip, non-inflammatory degenerative joint disease (nidjd), osteoarthritis, protrusio acetabuli, slipped capital femoral epiphyses, traumatic arthritis